# Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging

> **NCT01021618** · NA · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 140 (actual)

## Conditions studied

- Coronary Artery Disease
- Myocardial Ischemia

## Interventions

- **DRUG:** Regadenoson
- **OTHER:** Symptom-limited exercise

## Key facts

- **NCT ID:** NCT01021618
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2013-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021618, "Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01021618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*